Table 1.
Characteristics | Total | Malignant transformation | P‐value | |
---|---|---|---|---|
Yes n (%) | No n (%) | |||
150 | 23 (15.3) | 127 (84.7) | ||
Age (years) | ||||
Median | 62.3 | 66 | 61.7 | |
Range | 19–87 | 47–87 | 19–87 | |
≤65 | 85 | 12 (14.1) | 73 (85.9) | 0.637 |
>65 | 65 | 11 (16.9) | 54 (83.1) | |
Sex | ||||
Male | 76 | 9 (11.8) | 67 (88.2) | 0.229 |
Female | 74 | 14 (18.9) | 60 (81.1) | |
Oral subsite | ||||
Gingiva | 64 | 11 (17.2) | 53 (82.8) | 0.128 |
Tongue | 52 | 11 (21.2) | 41 (78.8) | |
Buccal mucosa | 21 | 1 (4.8) | 20 (95.2) | |
Others | 13 | 0 (0) | 13 (100) | |
Grade of dysplasia | ||||
None | 101 | 13 (12.9) | 88 (87.1) | 0.427 |
Mild | 37 | 7 (18.9) | 30 (81.1) | |
Moderate, severe | 12 | 3 (25.0) | 9 (75.0) | |
SMAD4 expression | ||||
High | 84 | 6 (7.1) | 78 (92.9) | 0.0017a |
Low | 66 | 17 (25.8) | 49 (74.2) | |
Lymphocyte infiltration | ||||
Low | 51 | 2 (3.9) | 49 (96.1) | 0.0054a |
High | 99 | 21 (21.2) | 78 (78.8) |
The chi‐square test was used to examine the correlation between malignant transformation and clinicopathological factors in 150 oral leukoplakia patients.
P < 0.01.